2020
DOI: 10.1126/scisignal.abc0653
|View full text |Cite
|
Sign up to set email alerts
|

Engineered IL-10 variants elicit potent immunomodulatory effects at low ligand doses

Abstract: Interleukin-10 (IL-10) is a dimeric cytokine with both immunosuppressive and immunostimulatory activities; however, IL-10–based therapies have shown only marginal clinical benefits. Here, we explored whether the stability of the IL-10 receptor complex contributes to the immunomodulatory potency of IL-10. We generated an IL-10 mutant with enhanced affinity for its IL-10Rβ receptor using yeast surface display. Compared to the wild-type cytokine, the affinity-enhanced IL-10 variants recruited IL-10Rβ more efficie… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
50
0

Year Published

2020
2020
2022
2022

Publication Types

Select...
8
1
1

Relationship

2
8

Authors

Journals

citations
Cited by 54 publications
(52 citation statements)
references
References 68 publications
(101 reference statements)
2
50
0
Order By: Relevance
“…2b), albeit exhibiting similar pSTAT1 amplitudes for IL-27 and HypIL-6, most likely because of the high endogenous levels of GP130 in RPE1 cells. We used previously described RPE1 GP130 KO cells (Figure 1-figure supplement 2) (35) to transfect and express tagged variants of IL-27R and GP130, to allow quantitative site-specific fluorescence cell surface labelling by dye-conjugated nanobodies (NBs) (Figure 1e) as recently described in (36). For both IL-27R and GP130 we found a random distribution and unhindered lateral diffusion of individual receptor monomers (Figure 1f).…”
Section: Ligand-induced Cell-surface Receptor Assembly By Il-27 and Hypil-6mentioning
confidence: 80%
“…2b), albeit exhibiting similar pSTAT1 amplitudes for IL-27 and HypIL-6, most likely because of the high endogenous levels of GP130 in RPE1 cells. We used previously described RPE1 GP130 KO cells (Figure 1-figure supplement 2) (35) to transfect and express tagged variants of IL-27R and GP130, to allow quantitative site-specific fluorescence cell surface labelling by dye-conjugated nanobodies (NBs) (Figure 1e) as recently described in (36). For both IL-27R and GP130 we found a random distribution and unhindered lateral diffusion of individual receptor monomers (Figure 1f).…”
Section: Ligand-induced Cell-surface Receptor Assembly By Il-27 and Hypil-6mentioning
confidence: 80%
“…Fig. 2a) ( 34 ) to transfect and express tagged variants of IL-27Rα and GP130, to allow quantitative site-specific fluorescence cell surface labelling by dye-conjugated nanobodies (NBs) (Figure 1e) as recently described in ( 35 ). For both IL-27Rα and GP130 we found a random distribution and unhindered lateral diffusion of individual receptor monomers (Figure 1f).…”
Section: Resultsmentioning
confidence: 99%
“…The combination of IL-10 and IL-2 supports CD8 T cell effector function. Specifically, CD8 T cells activated in vitro in the presence of the IL-10/IL-2 combination increase expression of granzyme B and downregulate genes associated with T cell exhaustion (68). In vitro activation with supplemental IL-10 alone has been shown to increase expression of granzymes and IFN-g (69).…”
Section: Discussionmentioning
confidence: 99%